NL181781C - Werkwijze voor het bereiden van een gevriesdroogd antitrombinepreparaat. - Google Patents

Werkwijze voor het bereiden van een gevriesdroogd antitrombinepreparaat.

Info

Publication number
NL181781C
NL181781C NLAANVRAGE7905220,A NL7905220A NL181781C NL 181781 C NL181781 C NL 181781C NL 7905220 A NL7905220 A NL 7905220A NL 181781 C NL181781 C NL 181781C
Authority
NL
Netherlands
Prior art keywords
antitrombine
freeze
dried
preparing
preparation
Prior art date
Application number
NLAANVRAGE7905220,A
Other languages
English (en)
Other versions
NL181781B (nl
NL7905220A (nl
Original Assignee
Green Cross Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp filed Critical Green Cross Corp
Publication of NL7905220A publication Critical patent/NL7905220A/nl
Publication of NL181781B publication Critical patent/NL181781B/nl
Application granted granted Critical
Publication of NL181781C publication Critical patent/NL181781C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NLAANVRAGE7905220,A 1978-01-07 1979-07-04 Werkwijze voor het bereiden van een gevriesdroogd antitrombinepreparaat. NL181781C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP53000714A JPS597693B2 (ja) 1978-01-07 1978-01-07 抗トロンビン製剤及びその製法
JP71478 1978-01-07

Publications (3)

Publication Number Publication Date
NL7905220A NL7905220A (nl) 1981-01-06
NL181781B NL181781B (nl) 1987-06-01
NL181781C true NL181781C (nl) 1987-11-02

Family

ID=11481420

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7905220,A NL181781C (nl) 1978-01-07 1979-07-04 Werkwijze voor het bereiden van een gevriesdroogd antitrombinepreparaat.

Country Status (10)

Country Link
US (1) US4340589A (nl)
JP (1) JPS597693B2 (nl)
BE (1) BE877439A (nl)
CA (1) CA1126652A (nl)
CH (1) CH645537A5 (nl)
FR (1) FR2460138A1 (nl)
GB (1) GB2064545B (nl)
NL (1) NL181781C (nl)
SE (1) SE459784B (nl)
WO (1) WO1980002798A1 (nl)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
US4363319A (en) * 1980-06-30 1982-12-14 Applied Medical Devices, Inc. Ready-to-use bandage incorporating a coagulant composition and method of preparing same
ATE12779T1 (de) * 1980-09-30 1985-05-15 Bayer Ag Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen.
DE3038163A1 (de) * 1980-10-09 1982-05-06 Boehringer Mannheim Gmbh, 6800 Mannheim Thrombininhibitor, seine herstellung und verwendung
JPS5967228A (ja) * 1982-10-07 1984-04-16 Green Cross Corp:The 寒冷不溶性グロブリンの凍結乾燥方法
JPS6054287B2 (ja) * 1983-10-19 1985-11-29 株式会社ミドリ十字 血漿蛋白の加熱処理方法
US4656254A (en) * 1985-12-02 1987-04-07 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor and antithrombin III
DE3624453A1 (de) * 1986-07-19 1988-01-28 Behringwerke Ag Verfahren zur herstellung von humanem antithrombin iii (atiii), dafuer geeignete vektoren und wirtszellen, so erhaltenes, biologisch aktives atiii und dieses enthaltende arzneimittel
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
US4894444A (en) * 1987-07-16 1990-01-16 Merck & Co., Inc. Recovery and purification of immunogens from immunogen-alum complexes
US4877608A (en) * 1987-11-09 1989-10-31 Rorer Pharmaceutical Corporation Pharmaceutical plasma protein formulations in low ionic strength media
CA1331133C (en) * 1988-03-01 1994-08-02 Michael Jon Pikal Pharmaceutical growth hormone formulations
CA1341379C (en) 1988-04-28 2002-07-23 Welfide Corporation Purified antithrombin-iii and methods of producing the same
WO1989011298A1 (en) * 1988-05-27 1989-11-30 Centocor, Inc. Formulation for antibody reagents
DE68908175T2 (de) * 1988-05-27 1994-03-03 Centocor Inc Gefriergetrocknete formulierung für antikörperprodukte.
US5252557A (en) * 1988-07-25 1993-10-12 Kiyoshi Kita Administration method of antithrombin
CA1336396C (en) * 1988-07-25 1995-07-25 Kiyoshi Kita Intraocular anticoagulant including antithrombin iii and method of administration
JPH0341033A (ja) * 1989-07-07 1991-02-21 Kyowa Hakko Kogyo Co Ltd 安定なモチリン類含有製剤
US5591431A (en) * 1990-03-09 1997-01-07 G.D. Searle & Co. Enhancement of clot lysis
AT402367B (de) * 1990-10-11 1997-04-25 Immuno Ag Pharmazeutische zubereitung auf basis von lys-plasminogen
JP3494667B2 (ja) * 1992-10-02 2004-02-09 アベンティス ファーマ株式会社 アンチトロンビンｉｉｉ製剤
EP0653212A4 (en) * 1993-04-05 1997-08-20 Green Cross Corp ANTITHROMBIN III COMPOSITION IN LIQUID FORM AND METHOD FOR STABILIZING IT.
WO1994022471A1 (en) * 1993-04-05 1994-10-13 The Green Cross Corporation Liquid antithrombin iii preparation and method of stabilizing the same
US5397479A (en) * 1993-04-26 1995-03-14 International Remote Imaging Systems, Inc. Composition and method for enrichment of white blood cells from whole human blood
US7045585B2 (en) * 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US6491965B1 (en) 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US6562781B1 (en) 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
EP0844254A3 (en) * 1996-11-20 1999-05-12 The Green Cross Corporation Method for producing antithrombin-III, method for purifying it, and preparation containing it
DE19856443A1 (de) * 1998-12-08 2000-06-21 Centeon Pharma Gmbh Stabilisiertes Antithrombin III-Präparat
US6518406B1 (en) * 1999-06-23 2003-02-11 Octapharma Ag Method for purification of proteins
SE9902388D0 (sv) * 1999-06-23 1999-06-23 Pharmacia & Upjohn Ab Method for purification of proteins
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US8563693B2 (en) * 2001-01-26 2013-10-22 Acceleration Biopharmaceuticals, Inc. Method of treating human immunodeficiency virus infection in a mammal comprising administering heparin-activated antithrombin III
WO2002058638A2 (en) * 2001-01-26 2002-08-01 The General Hospital Corporation Serpin drugs for treatment of hiv infection and method of use thereof
MXPA04002446A (es) 2001-09-26 2004-07-23 Baxter Int Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
US7498130B2 (en) 2003-05-13 2009-03-03 Massachusetts General Hospital Method of reducing viral load
US20040229778A1 (en) * 2003-05-13 2004-11-18 Elmaleh David R. Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases
ES2221817B1 (es) * 2004-07-26 2005-10-01 Probitas Pharma, S.A. "soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas".
MX2007015183A (es) * 2005-06-14 2008-02-19 Baxter Int Formulaciones farmaceuticas para minimizar las interacciones farmaco-farmaco.
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
EP2236520A1 (en) * 2009-03-31 2010-10-06 Leukocare Ag Stabilizing composition for immobilized biomolecules
MX2012005132A (es) 2009-11-03 2012-07-25 Grifols Therapeutics Inc Composicion, metodo y kit para inhibidor de alfa-1 proteinasa.
US8648177B2 (en) * 2009-11-24 2014-02-11 Grifols Therapeutics Inc. Lyophilization methods, compositions, and kits
EP2834635A4 (en) 2012-04-03 2015-09-02 Smiths Medical Asd Inc COMPOSITIONS WITH A HEPARINE ACCUMULATIVE AND METHOD THEREFOR
CN103041380B (zh) * 2012-12-28 2014-08-06 中国医学科学院输血研究所 人抗凝血酶制剂干热处理过程中的稳定剂
CN102973526B (zh) * 2012-12-28 2015-09-09 贵州泰邦生物制品有限公司 人抗凝血酶制剂冷冻干燥过程中的保护剂
US11872315B2 (en) * 2016-12-21 2024-01-16 Sun, Chung Chin Method for blood plasma protein activity preservation
CN111537326B (zh) * 2020-05-07 2023-05-16 天津德祥生物技术股份有限公司 制备冻干血小板的方法及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA958339A (en) * 1970-09-19 1974-11-26 Yoshio Yoshimura Stabilization of microorganism cells lytic enzyme
SE392038B (sv) * 1971-09-08 1977-03-14 Kabi Ab Forfarande for isolering av antitrombin ur blod eller blodprodukter
JPS5029005B2 (nl) * 1972-05-08 1975-09-19
JPS532931B2 (nl) * 1973-12-05 1978-02-01
US4087415A (en) * 1976-06-09 1978-05-02 William L. Wilson Antithrombin III
JPS6040859B2 (ja) * 1977-07-27 1985-09-12 喜温 三浦 抗血栓性人工医療材料

Also Published As

Publication number Publication date
SE459784B (sv) 1989-08-07
NL181781B (nl) 1987-06-01
WO1980002798A1 (en) 1980-12-24
GB2064545A (en) 1981-06-17
CA1126652A (en) 1982-06-29
BE877439A (fr) 1979-11-05
JPS597693B2 (ja) 1984-02-20
US4340589A (en) 1982-07-20
NL7905220A (nl) 1981-01-06
GB2064545B (en) 1983-03-09
JPS5495715A (en) 1979-07-28
CH645537A5 (en) 1984-10-15
SE8101065L (sv) 1981-02-17
FR2460138A1 (fr) 1981-01-23
FR2460138B1 (nl) 1982-10-08

Similar Documents

Publication Publication Date Title
NL181781C (nl) Werkwijze voor het bereiden van een gevriesdroogd antitrombinepreparaat.
NL7904674A (nl) Werkwijze voor de bereiding van een chitosan-glucancom- plex.
NL188901C (nl) Werkwijze voor het bereiden van een 1alfa-hydroxyvitamine d derivaat, alsmede de daarbij verkregen 1alfa-hydroxy-3,5-cyclovitamine d derivaten.
NL188162C (nl) Werkwijze voor het bereiden van een bestatinederivaat.
NL171660C (nl) Werkwijze voor het bereiden van een verfpreparaat voor keratinevezels.
NL185930C (nl) Werkwijze voor het bereiden van een polyurethanelastomeer.
NL7605451A (nl) Werkwijze voor het bereiden van een wasverzor- gend preparaat.
NL7904941A (nl) Werkwijze voor het bereiden van arylpyrodruivenzuren.
NL177890C (nl) Werkwijze voor het bereiden van een cosmetisch lippenroodpreparaat.
NL7902521A (nl) Werkwijze voor het bereiden van 2,2,6,6-tetramethyl- -4-piperidon.
NL7903975A (nl) Werkwijze voor het bereiden van pregnaanderivaten.
NL7904585A (nl) Werkwijze voor het bereiden van 1-hydroxycalciferol- derivaten.
NL179785B (nl) Werkwijze voor de bereiding van een zonnepreparaat.
NL7604777A (nl) Werkwijze voor het bereiden van een weefselver- frissend preparaat.
NL179446C (nl) Werkwijze voor het bereiden van instantpuree.
NL7903148A (nl) Werkwijze voor het bereiden van methylformiaat.
NL7904165A (nl) Werkwijze voor het bereiden van een cyano-azo-kleur- stof.
NL7805438A (nl) Werkwijze voor het bereiden van p-hydroxyfenylazijnzuur.
NL7706619A (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat.
NL7900678A (nl) Werkwijze voor het bereiden van aardalkalimercaptiden.
NL7804880A (nl) Werkwijze voor het bereiden van 3-halogeen-2- -hydroxyalkyltrialkylammoniumchloriden.
NL7901164A (nl) Werkwijze voor het bereiden van beta-santalol, beta-santaleen, dihydro-beta-santalol en verwante verbindingen.
NL188286C (nl) Werkwijze voor het bereiden van een 1alfa-hydroxyvitamine d verbinding.
NL192833B (nl) Werkwijze voor het bereiden van een beta-hydroxyisoboterzuur.
NL7600791A (nl) Werkwijze voor het bereiden van een kosmetisch preparaat.

Legal Events

Date Code Title Description
A1C A request for examination has been filed
A85 Still pending on 85-01-01
V1 Lapsed because of non-payment of the annual fee

Effective date: 19970201